Vivosynth Technologies' flagship product, ModuLab, is an automated system designed to optimize cloning, the underlying process of synthetic biology. We anticipate a huge increase in cloning activity within the global biotechnology industry over the next decade. Our target market, therefore, comprises all companies and institutions that would benefit from a highly efficient, automated cloning system.